Because restoration of ERα expression renders endometrial cancer cells susceptible to megestrol acetate treatment [26], we investigated whether combined treatment with palbociclib and megestrol acetate could exert synergistic antiproliferative effects. This evidence concerns the gene ESR1 and endometrial cancer.